| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |